Table 2 Clinical and pathological data of the fresh-frozen tissues included in this study
From: MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis
Clinicopathological data cohort #1 | PCa (n = 198) | PIN (n = 37 matched with a PCa) | MNPT (n = 10) |
|---|---|---|---|
Age (years), median (range) | 64 [49–75] | 65 [51–75] | 58 [45–79] |
PSA (ng/mL), median (range) | 8.10 (2.66–35.50) | n.a. | n.a. |
Pathological stage, N (%) | |||
pT2 | 110 (55.6 %) | n.a. | n.a. |
pT3a | 65 (32.8 %) | n.a. | n.a. |
pT3b | 23 (11.6 %) | n.a. | n.a. |
Gleason score, N (%) | |||
<7 | 67 (33.8 %) | n.a. | n.a. |
=7 | 115 (58.1 %) | n.a. | n.a. |
>7 | 16 (8.1 %) | n.a. | n.a. |
